Not available outside of the UK & Ireland.
Biochem/physiol Actions
Partial agonist for µ and κ opioid receptors.
Features and Benefits
This compound was developed by Abbott. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
General description
Nalbuphine functions as an analgesic. It has anti catabolic properties. Nalbuphine maybe associated with sedation, nausea and vomiting.
Packaging
25, 100 mg in glass bottle
This product has met the following criteria to qualify for the following awards: